{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:22:01Z","timestamp":1791084121824,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/nbt.3469","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T10:54:03Z","timestamp":1454324043000},"page":"334-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":524,"title":["A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice"],"prefix":"10.1038","volume":"34","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"McMenamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenning","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Morizono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Musunuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L","family":"Batshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,1]]},"reference":[{"key":"BFnbt3469_CR1","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/mt.2008.72","volume":"16","author":"SC Cunningham","year":"2008","unstructured":"Cunningham, S.C., Dane, A.P., Spinoulas, A., Logan, G.J. & Alexander, I.E. Gene delivery to the juvenile mouse liver using AAV2\/8 vectors. Mol. Ther. 16, 1081\u20131088 (2008).","journal-title":"Mol. Ther."},{"key":"BFnbt3469_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/hum.2011.183","volume":"23","author":"L Wang","year":"2012","unstructured":"Wang, L., Wang, H., Bell, P., McMenamin, D. & Wilson, J.M. Hepatic gene transfer in neonatal mice by adeno-associated virus serotype 8 vector. Hum. Gene Ther. 23, 533\u2013539 (2012).","journal-title":"Hum. Gene Ther."},{"key":"BFnbt3469_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ymgme.2014.08.001","volume":"113","author":"ML Batshaw","year":"2014","unstructured":"Batshaw, M.L., Tuchman, M., Summar, M., Seminara, J. & Members of the Urea Cycle Disorders Consortium. A longitudinal study of urea cycle disorders. Mol. Genet. Metab. 113, 127\u2013130 (2014).","journal-title":"Mol. Genet. Metab."},{"key":"BFnbt3469_CR4","unstructured":"Lichter-Konecki, U., Caldovic, L., Morizono, H. & Simpson, K. Ornithine transcarbamylase deficiency (1993\u20132013). in GeneReviews (eds. Pagon, R.A. et al.) \n                    http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK154378\/\n                    \n                   (29 August 2013)."},{"key":"BFnbt3469_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jpeds.2012.06.065","volume":"162","author":"N Ah Mew","year":"2013","unstructured":"Ah Mew, N., Krivitzky, L., McCarter, R., Batshaw, M., Tuchman, M. & Urea Cycle Disorders Consortium of the Rare Diseases Clinical Research Network. Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ. J. Pediatr. 162, 324\u20139.e1 (2013).","journal-title":"J. Pediatr."},{"key":"BFnbt3469_CR6","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1073\/pnas.86.11.4142","volume":"86","author":"PE Hodges","year":"1989","unstructured":"Hodges, P.E. & Rosenberg, L.E. The spfash mouse: a missense mutation in the ornithine transcarbamylase gene also causes aberrant mRNA splicing. Proc. Natl. Acad. Sci. USA 86, 4142\u20134146 (1989).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt3469_CR7","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1182\/blood-2014-12-615492","volume":"126","author":"R Sharma","year":"2015","unstructured":"Sharma, R. et al. In vivo genome editing of the albumin locus as a platform for protein replacement therapy. Blood 126, 1777\u20131784 (2015).","journal-title":"Blood"},{"key":"BFnbt3469_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nbt.2884","volume":"32","author":"H Yin","year":"2014","unstructured":"Yin, H. et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 32, 551\u2013553 (2014).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt3469_CR9","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1182\/blood-2013-04-497354","volume":"122","author":"XM Anguela","year":"2013","unstructured":"Anguela, X.M. et al. Robust ZFN-mediated genome editing in adult hemophilic mice. Blood 122, 3283\u20133287 (2013).","journal-title":"Blood"},{"key":"BFnbt3469_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nature13864","volume":"517","author":"A Barzel","year":"2015","unstructured":"Barzel, A. et al. Promoterless gene targeting without nucleases ameliorates haemophilia B in mice. Nature 517, 360\u2013364 (2015).","journal-title":"Nature"},{"key":"BFnbt3469_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran, F.A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186\u2013191 (2015).","journal-title":"Nature"},{"key":"BFnbt3469_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13059-015-0817-8","volume":"16","author":"AE Friedland","year":"2015","unstructured":"Friedland, A.E. et al. Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications. Genome Biol. 16, 257 (2015).","journal-title":"Genome Biol."},{"key":"BFnbt3469_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature14592","volume":"523","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver, B.P. et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523, 481\u2013485 (2015).","journal-title":"Nature"},{"key":"BFnbt3469_CR14","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu, P.D., Lander, E.S. & Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262\u20131278 (2014).","journal-title":"Cell"},{"key":"BFnbt3469_CR15","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna, J.A. & Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096 (2014).","journal-title":"Science"},{"key":"BFnbt3469_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1089\/hum.2015.087","volume":"26","author":"D Wang","year":"2015","unstructured":"Wang, D. et al. Adenovirus-mediated somatic genome editing of Pten by CRISPR\/Cas9 in mouse liver in spite of Cas9-specific immune responses. Hum. Gene Ther. 26, 432\u2013442 (2015).","journal-title":"Hum. Gene Ther."},{"key":"BFnbt3469_CR17","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1016\/j.febslet.2014.09.008","volume":"588","author":"R Cheng","year":"2014","unstructured":"Cheng, R. et al. Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR\/Cas9. FEBS Lett. 588, 3954\u20133958 (2014).","journal-title":"FEBS Lett."},{"key":"BFnbt3469_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/hep.510240219","volume":"24","author":"MA Dingemanse","year":"1996","unstructured":"Dingemanse, M.A. et al. Development of the ornithine cycle in rat liver: zonation of a metabolic pathway. Hepatology 24, 407\u2013411 (1996).","journal-title":"Hepatology"},{"key":"BFnbt3469_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/biot.201400529","volume":"10","author":"F Schmidt","year":"2015","unstructured":"Schmidt, F. & Grimm, D. CRISPR genome engineering and viral gene delivery: a case of mutual attraction. Biotechnol. J. 10, 258\u2013272 (2015).","journal-title":"Biotechnol. J."},{"key":"BFnbt3469_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nrmicro1266","volume":"3","author":"A Vasileva","year":"2005","unstructured":"Vasileva, A. & Jessberger, R. Precise hit: adeno-associated virus in gene targeting. Nat. Rev. Microbiol. 3, 837\u2013847 (2005).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFnbt3469_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nbt.3241","volume":"33","author":"AJ Mahiny","year":"2015","unstructured":"Mahiny, A.J. et al. In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency. Nat. Biotechnol. 33, 584\u2013586 (2015).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt3469_CR22","doi-asserted-by":"publisher","first-page":"11854","DOI":"10.1073\/pnas.182412299","volume":"99","author":"GP Gao","year":"2002","unstructured":"Gao, G.P. et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99, 11854\u201311859 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt3469_CR23","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1038\/mt.2011.151","volume":"19","author":"L Wang","year":"2011","unstructured":"Wang, L. et al. AAV8-mediated hepatic gene transfer in infant rhesus monkeys (Macaca mulatta). Mol. Ther. 19, 2012\u20132020 (2011).","journal-title":"Mol. Ther."},{"key":"BFnbt3469_CR24","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1038\/ncomms6507","volume":"5","author":"L Yang","year":"2014","unstructured":"Yang, L. et al. Targeted and genome-wide sequencing reveal single nucleotide variations impacting specificity of Cas9 in human stem cells. Nat. Commun. 5, 5507 (2014).","journal-title":"Nat. Commun."},{"key":"BFnbt3469_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai, S.Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33, 187\u2013197 (2015).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt3469_CR26","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/gt.2013.22","volume":"20","author":"Y Shi","year":"2013","unstructured":"Shi, Y., Falahati, R., Zhang, J., Flebbe-Rehwaldt, L. & Gaensler, K.M. Role of antigen-specific regulatory CD4+CD25+ T cells in tolerance induction after neonatal IP administration of AAV-hF.IX. Gene Ther. 20, 987\u2013996 (2013).","journal-title":"Gene Ther."},{"key":"BFnbt3469_CR27","doi-asserted-by":"publisher","first-page":"397879","DOI":"10.1155\/2015\/397879","volume":"2015","author":"MS Nivsarkar","year":"2015","unstructured":"Nivsarkar, M.S. et al. Evidence for contribution of CD4+ CD25+ regulatory T cells in maintaining immune tolerance to human factor IX following perinatal adenovirus vector delivery. J. Immunol. Res. 2015, 397879 (2015).","journal-title":"J. Immunol. Res."},{"key":"BFnbt3469_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/156652309787909490","volume":"9","author":"PA LoDuca","year":"2009","unstructured":"LoDuca, P.A., Hoffman, B.E. & Herzog, R.W. Hepatic gene transfer as a means of tolerance induction to transgene products. Curr. Gene Ther. 9, 104\u2013114 (2009).","journal-title":"Curr. Gene Ther."},{"key":"BFnbt3469_CR29","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/mt.2015.99","volume":"23","author":"C Hinderer","year":"2015","unstructured":"Hinderer, C. et al. Neonatal systemic AAV induces tolerance to CNS gene therapy in MPS I dogs and nonhuman primates. Mol. Ther. 23, 1298\u20131307 (2015).","journal-title":"Mol. Ther."},{"key":"BFnbt3469_CR30","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1089\/hum.2010.055","volume":"21","author":"M Lock","year":"2010","unstructured":"Lock, M. et al. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum. Gene Ther. 21, 1259\u20131271 (2010).","journal-title":"Hum. Gene Ther."},{"key":"BFnbt3469_CR31","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F.A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"BFnbt3469_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ymthe.2006.03.009","volume":"14","author":"D Moscioni","year":"2006","unstructured":"Moscioni, D. et al. Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors. Mol. Ther. 14, 25\u201333 (2006).","journal-title":"Mol. Ther."},{"key":"BFnbt3469_CR33","first-page":"195","volume":"246","author":"TM Daly","year":"2004","unstructured":"Daly, T.M. AAV-mediated gene transfer to the liver. Methods Mol. Biol. 246, 195\u2013199 (2004).","journal-title":"Methods Mol. Biol."},{"key":"BFnbt3469_CR34","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1203\/00006450-200012000-00023","volume":"48","author":"L Augustin","year":"2000","unstructured":"Augustin, L., Mavinakere, M., Morizono, H. & Tuchman, M. Expression of wild-type and mutant human ornithine transcarbamylase genes in Chinese hamster ovary cells and lack of dominant negative effect of R141Q and R40H mutants. Pediatr. Res. 48, 842\u2013846 (2000).","journal-title":"Pediatr. Res."},{"key":"BFnbt3469_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/bj3220625","volume":"322","author":"H Morizono","year":"1997","unstructured":"Morizono, H. et al. Expression, purification and kinetic characterization of wild-type human ornithine transcarbamylase and a recurrent mutant that produces 'late onset' hyperammonaemia. Biochem. J. 322, 625\u2013631 (1997).","journal-title":"Biochem. J."},{"key":"BFnbt3469_CR36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/gt.2011.111","volume":"19","author":"L Wang","year":"2012","unstructured":"Wang, L. et al. Sustained correction of OTC deficiency in spf(ash) mice using optimized self-complementary AAV2\/8 vectors. Gene Ther. 19, 404\u2013410 (2012).","journal-title":"Gene Ther."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nbt.3469.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.3469","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.3469.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:33:04Z","timestamp":1684420384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt.3469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,1]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFnbt3469"],"URL":"https:\/\/doi.org\/10.1038\/nbt.3469","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726111852.793540447","asserted-by":"object"}]},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,1]]},"assertion":[{"value":"23 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.M. Wilson is an advisor to REGENXBIO, Dimension Therapeutics and Solid Gene Therapy, and is a founder of, holds equity in, and has a sponsored research agreement with REGENXBIO and Dimension Therapeutics; in addition, he is a consultant to several biopharmaceutical companies and is an inventor on patents licensed to various biopharmaceutical companies.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}